EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): MiscellaneousNewron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry 28.03.2023 / 12:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Newron presen.
Presentation will include full data from the six-month interim timepoint from the cohort of the first 100 patients randomized in study 014/015, a Phase II trial evaluating evenamide as add-on therapy
EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): ConferenceNewron to present at the 31st European Congress of Psychiatry 17.03.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Newron to present at the 31st European Congress of PsychiatryPresentation will include ful.